OFIX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Orthofix Medical Inc (OFIX) is not a strong buy for a beginner, long-term investor at this time. The stock shows weak financial performance, bearish technical indicators, and lacks positive catalysts or strong trading signals. A hold is recommended until clearer signs of improvement emerge.
The technical indicators are bearish. The MACD is slightly positive but expanding, while the RSI is neutral at 41.05. The moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 11.514, with resistance at 12.165. The stock trend analysis suggests a potential decline in the next week and month.
NULL identified. No recent news or significant insider/hedge fund activity. Analysts maintain Buy ratings but have lowered price targets.
Weak financial performance in Q4 2025, with a significant drop in net income (-92.38% YoY) and EPS (-92.00% YoY). Analysts have lowered price targets, and the stock lacks recent trading signals or positive sentiment.
In Q4 2025, revenue increased by 1.97% YoY to $219.91M, but net income dropped significantly to -$2.22M (-92.38% YoY), and EPS fell to -$0.06 (-92.00% YoY). Gross margin improved slightly to 69.7% (+4.03% YoY).
Analysts maintain Buy ratings but have lowered price targets recently. Stifel lowered the target to $18, Canaccord to $20, and Barrington to $17, citing slower-than-expected EBITDA margin improvements and top-line acceleration.
